A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants

Clinical trial NCT03286751 · COMPLETED

Trial details

NCT number: NCT03286751
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2017-10-13
Primary completion: 2018-02-06
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.